Johnson & Johnson Innovation – JJDC — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Hyalexhyalex.comin𝕏Series A · May 2017 · $16M
HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.
HealthtechMedical DevicesLexington, US
Carl Vause(Executive Officer, Director)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)
BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in
Co-investorsCanaan PartnersOUP (Osage University Partners)Treo Ventures, Llc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.